Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $546.3 million.

  • United Therapeutics' Total Current Liabilities fell 3745.13% to $546.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $546.3 million, marking a year-over-year decrease of 3745.13%. This contributed to the annual value of $738.1 million for FY2024, which is 824.22% down from last year.
  • Per United Therapeutics' latest filing, its Total Current Liabilities stood at $546.3 million for Q3 2025, which was down 3745.13% from $527.1 million recorded in Q2 2025.
  • United Therapeutics' Total Current Liabilities' 5-year high stood at $873.4 million during Q3 2024, with a 5-year trough of $292.6 million in Q1 2022.
  • Its 5-year average for Total Current Liabilities is $519.2 million, with a median of $370.3 million in 2023.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 16512.63% in 2024, then plummeted by 3745.13% in 2025.
  • United Therapeutics' Total Current Liabilities (Quarter) stood at $305.4 million in 2021, then grew by 12.38% to $343.2 million in 2022, then surged by 134.38% to $804.4 million in 2023, then decreased by 8.24% to $738.1 million in 2024, then fell by 25.99% to $546.3 million in 2025.
  • Its Total Current Liabilities stands at $546.3 million for Q3 2025, versus $527.1 million for Q2 2025 and $721.5 million for Q1 2025.